Table 1. Sample characterization, prevalence, and mean/standard deviation of ankle lesions and their association with the studied variables (n = 70).
| Total n (%) | BBT n (%) | MBT n (%) | Benign STT n (%) | Malignant STT n (%) | Infection n (%) | ||
|---|---|---|---|---|---|---|---|
| 39 (55.71%) | 14 (20%) | 4 (5.71%) | 6 (8.57%) | 7 (10%) | |||
| Sex | 0.082* | ||||||
| Women | 41 (58.57%) | 22 (53.66%) | 12 (29.27%) | 1 (2.44%) | 2 (4.88%) | 4 (9.76%) | |
| Men | 29 (41.43%) | 17 (58.62%) | 2 (6.9%) | 3 (10.34%) | 4 (13.79%) | 3 (10.34%) | |
| Age (mean/SD) | 21.66 ± 2.29 | 17.08 ± 1.84 | 27.31 ± 7.75 | 42.75 ± 13.87 | 35 ± 6.06 | 12.57 ± 6.35 | 0.064** |
| Pain | 0.852* | ||||||
| No | 14 (22.95%) | 9 (64.29%) | 1 (7.14%) | 1 (7.14%) | 2 (14.29%) | 1 (7.14%) | |
| Yes | 47 (77.05%) | 26 (55.32%) | 8 (17.02%) | 3 (6.38%) | 4 (8.51%) | 6 (12.77%) | |
| Local volume increase | 0.000* | ||||||
| No | 28 (44.44%) | 25 (89.29%) | 2 (7.14%) | 0 (0%) | 0 (0%) | 1 (3.57%) | |
| Yes | 35 (55.56%) | 12 (34.29%) | 8 (22.86%) | 3 (8.57%) | 6 (17.14%) | 6 (17.14%) | |
| Fracture | 0.180* | ||||||
| No | 58 (86.57%) | 34 (58.62%) | 11 (18.97%) | 4 (6.9%) | 5 (8.62%) | 4 (6.9%) | |
| Yes | 9 (13.43%) | 4 (44.44%) | 1 (11.11%) | 0 (0%) | 1 (11.11%) | 3 (33.33%) | |
| Duration of symptoms until treatment (mean/SD) | 17.40 ± 4.61 | 20.04 ± 6.69 | 5.78 ± 1.10 | 72 ± 48 | 30 ± 6 | 2.57 ± 0.68 | 0.539** |
| Diagnosis time (mean/SD) | 10.13 ± 0.86 | 5.31 ± 0.80 | 13.85 ± 0.85 | 16.5 ± 4.79 | 17.5 ± 0.34 | 19.57 ± 0.30 | 0.000* |
| Surgical treatment | 0.299* | ||||||
| No | 17 (26.56%) | 13 (26.56%) | 3 (17.65%) | 1 (5.88%) | 0 (0%) | 0 (0%) | |
| Yes | 47 (73.44%) | 23 (73.44%) | 11 (23.4%) | 3 (6.38%) | 6 (12.77%) | 4 (8.51%) | |
| Affected side | 0.230* | ||||||
| Left | 30 (46.15%) | 14 (46.67%) | 5 (16.67%) | 1 (3.33%) | 4 (13.33%) | 6 (20%) | |
| Right | 32 (49.23%) | 19 (59.38 %) | 8 (25%) | 2 (6.25%) | 2 (6.25%) | 1 (3.13%) | |
| Both | 3 (4.62%) | 2 (66.67%) | 0 (0%) | 1 (33.33%) | 0 (0%) | 0 (0%) | |
| Recurrence | 0.955* | ||||||
| No | 41 (77.36%) | 20 (48.78%) | 9 (21.95%) | 3 (7.32%) | 5 (12.2%) | 4 (9.76%) | |
| Yes | 12 (22.64%) | 7 (58.33%) | 3 (25%) | 1 (8.33%) | 1 (8.33%) | 0 (0%) |
BBT: benign bone tumor; MBT: malignant bone tumor; Benign STT: benign soft tissue tumor; Malignant STT: malignant soft tissue tumor; SD: standard deviation; *Fisher exact test; **ANOVA; p < 0.05: statistically significant.